BOCOM International Holdings Company Limited (HKG:3329)
Hong Kong · Delayed Price · Currency is HKD | Market Cap | 1.05B +45.3% |
| Revenue (ttm) | 530.47M |
| Net Income | -265.80M |
| EPS | -0.10 |
| Shares Out | 2.73B |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 23,657,000 |
| Open | 0.4200 |
| Previous Close | 0.4100 |
| Day's Range | 0.3800 - 0.4200 |
| 52-Week Range | 0.2800 - 1.0800 |
| Beta | 0.71 |
| Analysts | Strong Buy |
| Price Target | 0.58 (+50.65%) |
| Earnings Date | Aug 25, 2026 |
About HKG:3329
BOCOM International Holdings Company Limited, an investment holding company, provides securities brokerage, margin financing, corporate finance and underwriting, investment and loans, asset management, and advisory businesses in Hong Kong and the Mainland China. The company operates through Brokerage, Corporate Finance and Underwriting, Asset Management and Advisory, Margin Financing, Investment and Loans, and Others segments. The Brokerage segment provides trading and brokerage services for stocks, bonds, futures, options, and other marketable... [Read more]
Financial Performance
Financial StatementsNews
Cancer screening company Faces Tough IPO Test As Market Cools
Ammunition Life-tech has commercially launched five diagnostic tests for various types of cancer but could struggle to win over investors at an elevated valuation Key Takeaways: The company's combined...